TrimRx's Blog

Mounjaro reduces binge eating episodes by 60–70% in clinical observations through GLP-1 and GIP receptor agonism that normalizes hunger signaling.

Mounjaro produces 3-5% body weight loss in month one through dual GIP/GLP-1 action — slower than expected but clinically significant with proper titration.

Mounjaro can trigger or worsen body dysmorphia through rapid weight loss and shifting self-perception. Understand the psychological risks and warning

Mounjaro doesn’t cause eating disorders but can worsen existing patterns. Learn how GLP-1 therapy interacts with disordered eating and when it’s

Most Mounjaro patients lose 12–15% of body weight in 3 months — here’s the science behind it, realistic timelines, and what happens at each dose level.

Mounjaro delivers 15-22% body weight reduction in six months when combined with dietary adjustments and weekly injections at therapeutic doses.

Mounjaro 2 year results show sustained weight loss averaging 15-21% body weight at 104 weeks, with metabolic benefits persisting across long-term use.

Mounjaro long-term studies show sustained 15–21% weight loss at 72+ weeks, but 5-year data remains limited. Evidence, expectations, and realistic outcomes.

Mounjaro 1 year results show 15–22.5% body weight loss in clinical trials. Most patients maintain results with consistent dosing and lifestyle habits.